Publications
Showing all years
Patient-reported well-being using tildrakizumab in a real-world setting: 52-week interim data of the phase IV POSITIVE study
Reducing self-stigma in chronic skin disease - Development and pilot-test of the HautKompass online programme
Tackling self-stigma in chronic skin disease – Development and evaluation of the SkinCompass Online Programme
Unterdiagnostiziert und unterbehandelt
Patient needs in women of childbearing age with psoriasis: retrospective analysis from the German PsoBest registry
DOI:
Safety of tildrakizumab in patients with moderate-to-severe psoriasis: 52-week data from the phase IV POSITIVE study
Patients with psoriasis perceive major life changing events in physical, psychological and care dimensions: results from the DermCLCI-r-questionnaire in routine care
High effectiveness of tildrakizumab regardless of baseline characteristics in patients with moderate-to-severe psoriasis: 52-week results from the POSITIVE study
Predictors and mechanisms of self‐stigma in five chronic skin diseases: A systematic review
PMID:
DOI:
Personal, Financial and Time Burden in Inherited Ichthyoses: A Survey of 144 Patients in a University-based Setting
PMID:
DOI:
Thank you for your response
I am...